Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | thymidine kinase, putative | 0.0248 | 0.5963 | 0.5 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0248 | 0.5963 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0057 | 0 | 0.5 |
Entamoeba histolytica | thymidine kinase, putative | 0.0248 | 0.5963 | 0.5 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0248 | 0.5963 | 0.5 |
Trypanosoma brucei | thymidine kinase | 0.0248 | 0.5963 | 0.5 |
Trypanosoma cruzi | thymidine kinase, putative | 0.0248 | 0.5963 | 0.5 |
Leishmania major | thymidine kinase, putative | 0.0248 | 0.5963 | 0.5 |
Trichomonas vaginalis | thymidine kinase, putative | 0.0248 | 0.5963 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
T1/2 (ADMET) | = 11 min | t1/2 in monkey liver microsomes | ChEMBL. | 7731021 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.